Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
China · Delayed Price · Currency is CNY 19.34
-0.42 (-2.13%)
Sep 11, 2026, 3:04 PM CST
SHE:002287 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 11,202 | 13,473 | 11,346 | 11,924 | 12,061 | 16,133 | |
Market Cap Growth | -29.84% | 18.75% | -4.85% | -1.14% | -25.24% | 17.84% |
Enterprise Value | 9,223 | 11,487 | 9,899 | 11,823 | 11,263 | 15,564 |
Last Close Price | 19.76 | 23.18 | 20.23 | 20.75 | 20.73 | 27.06 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 16.78 | 20.78 | 19.49 | 20.52 | 25.52 | 22.54 |
Forward PE | - | 43.51 | 43.51 | 43.51 | 43.51 | 43.51 |
PS Ratio | 5.05 | 5.58 | 4.85 | 5.83 | 5.90 | 9.11 |
PB Ratio | 2.18 | 2.70 | 2.76 | 3.16 | 3.56 | 5.01 |
P/TBV Ratio | 2.33 | 2.90 | 3.04 | 3.54 | 4.07 | 5.83 |
P/FCF Ratio | 35.13 | 23.37 | 56.36 | 26.00 | 907.60 | 17.74 |
P/OCF Ratio | 23.44 | 18.46 | 24.84 | 17.20 | 42.22 | 15.59 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 4.16 | 4.76 | 4.23 | 5.78 | 5.51 | 8.79 |
EV/EBITDA Ratio | 13.60 | 15.53 | 14.89 | 21.38 | 18.64 | 32.65 |
EV/EBIT Ratio | 17.20 | 19.02 | 18.44 | 25.29 | 21.34 | 37.37 |
EV/FCF Ratio | 28.93 | 19.92 | 49.17 | 25.78 | 847.54 | 17.11 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Debt / Equity Ratio | 0.18 | 0.19 | 0.41 | 0.41 | 0.50 | 0.45 |
Debt / EBITDA Ratio | 1.35 | 1.25 | 2.51 | 2.74 | 2.78 | 3.01 |
Debt / FCF Ratio | 2.88 | 1.61 | 8.44 | 3.35 | 127.68 | 1.60 |
Net Debt / Equity Ratio | -0.39 | -0.42 | -0.32 | -0.22 | -0.15 | -0.16 |
Net Debt / EBITDA Ratio | -3.01 | -2.85 | -1.95 | -1.50 | -0.84 | -1.06 |
Net Debt / FCF Ratio | -6.35 | -3.66 | -6.45 | -1.81 | -37.99 | -0.56 |
Asset Turnover | 0.33 | 0.35 | 0.36 | 0.34 | 0.36 | 0.35 |
Inventory Turnover | 1.43 | 1.71 | 2.46 | 2.29 | 2.64 | 2.53 |
Quick Ratio | 2.70 | 2.35 | 2.37 | 2.40 | 2.23 | 2.12 |
Current Ratio | 2.99 | 2.57 | 2.50 | 2.57 | 2.35 | 2.25 |
Return on Equity (ROE) | 14.26% | 14.22% | 14.75% | 16.18% | 14.21% | 24.28% |
Return on Assets (ROA) | 4.94% | 5.51% | 5.13% | 4.79% | 5.76% | 5.19% |
Return on Invested Capital (ROIC) | 14.76% | 18.55% | 16.78% | 14.44% | 17.06% | 15.90% |
Return on Capital Employed (ROCE) | 9.90% | 11.50% | 10.50% | 9.30% | 11.70% | 9.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 5.90% | 4.81% | 5.13% | 4.87% | 3.92% | 4.44% |
FCF Yield | 2.85% | 4.28% | 1.77% | 3.85% | 0.11% | 5.64% |
Dividend Yield | 2.33% | 1.77% | 1.88% | 2.31% | 1.88% | 2.18% |
Payout Ratio | 86.40% | 69.87% | 48.51% | 37.86% | 72.06% | 27.31% |
Buyback Yield / Dilution | -5.85% | -2.50% | -0.03% | 0.05% | -0.21% | -0.12% |
Total Shareholder Return | -3.52% | -0.73% | 1.85% | 2.36% | 1.67% | 2.07% |